Literature DB >> 19393287

SELDI-TOF MS detection of urinary hepcidin.

Sandro Altamura1, Judit Kiss, Claudia Blattmann, Wolfgang Gilles, Martina U Muckenthaler.   

Abstract

Hepcidin is a 25-residue hepatic peptide that regulates iron absorption from the diet and tissue iron distribution. Inappropriately low Hepcidin expression is implicated in the pathogenesis of hereditary hemochromatosis and iron-loading anemias, like the thalassemias. Increased hepcidin expression mediates iron retention in the anemias of inflammation and plays a pathogenic role in iron-refractory iron-deficiency anemia (IRIDA). Because of its clinical importance, Hepcidin is expected to be a useful biomarker for diagnosis and management of iron-related disorders. So far an ELISA for human hepcidin and SELDI-TOF-MS based approaches have been applied to monitor urinary and/or serum hepcidin levels. Here we report a modified protocol for SELDI-TOF based detection of human, urinary hepcidin. We show that CM10 Proteinchips are superior to NP20 Proteinchips commonly used in previously reported protocols to sensitively and accurately detect urinary hepcidin. Application of this modified hepcidin assay accurately detects increased hepcidin levels in the urine of sepsis patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393287     DOI: 10.1016/j.biochi.2009.04.010

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

1.  Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method.

Authors:  Sun-Il Hwang; Yong-Yook Lee; Jung-Ok Park; H James Norton; Elene Clemens; Laura W Schrum; Herbert L Bonkovsky
Journal:  Clin Chim Acta       Date:  2011-08-16       Impact factor: 3.786

2.  A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.

Authors:  Sandro Altamura; Flavia D'Alessio; Barbara Selle; Martina U Muckenthaler
Journal:  Biochem J       Date:  2010-11-01       Impact factor: 3.857

3.  Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation.

Authors:  N Jaekel; K Lieder; S Albrecht; O Leismann; K Hubert; G Bug; N Kröger; U Platzbecker; M Stadler; K de Haas; S Altamura; M U Muckenthaler; D Niederwieser; H K Al-Ali
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

4.  High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine.

Authors:  Damon S Anderson; Matthew M Heeney; Udo Roth; Christoph Menzel; Mark D Fleming; Hanno Steen
Journal:  Anal Chem       Date:  2010-02-15       Impact factor: 6.986

Review 5.  Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agents.

Authors:  Lisa Lombardi; Giuseppantonio Maisetta; Giovanna Batoni; Arianna Tavanti
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.